INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Kitov Pharmaceuticals Holdings Ltd. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES--()--Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kitov Pharmaceuticals Holdings Ltd. (“Kitov” or the “Company”) (Nasdaq: KTOV). Investors who purchased or otherwise acquired Kitov shares between November 20, 2015 and February 3, 2017 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the April 10, 2017 lead plaintiff deadline.

If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights free of charge. You can also reach us through the firm’s website at, or by email at

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

On February 6, 2017, the Israeli publication Calcalist disclosed that Kitov’s Chief Executive Officer, Isaac Israel, had been detained by the Israeli Securities Authority due to allegations of publishing misleading information regarding a recent clinical trial of one of Kitov’s products. When this information was announced to the public, the value of Kitov stock fell, causing investors harm.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401

Recent Stories

RSS feed for Goldberg Law PC

Goldberg Law PC